User Auth Test Page

Questions Over Association Between COVID-19 Vaccine Reactions, Immunity Rise As People Receive New Boosters

MedPage Today (11/1, Fiore) reports many people are wondering whether “a strong reaction to the COVID-19 vaccine” is “a sign of a more robust immune response that ultimately brings better protection against infection, hospitalization, and death” as “they...

Full Article
Children’s Hospitals Struggling To Meet Demand Amid RSV Spike

The New York Times (11/1, Baumgaertner, Davis) reports the “drastic and unusually early spike in” respiratory syncytial virus (RSV) “is overwhelming pediatric units across the United States, bringing long waits for treatment and prompting hospital systems...

Full Article
CDC Issues Health Advisory Over Waterborne Bacteria In Dental Plumbing Systems After Outbreaks Of Nontuberculous Mycobacteria

NBC News (11/1, Alsharif) reports that on Monday, the CDC “issued a health advisory about waterborne bacteria in dental plumbing systems after children who visited pediatric dental clinics were infected with nontuberculous Mycobacteria.” The article adds,...

Full Article
Three Experimental Ebola Vaccine Candidates Sent To Uganda To Help Combat Outbreak

The Hill (11/1, Hou) reports, “Three experimental Ebola vaccine candidates are being shipped to Uganda to aid in combatting the ongoing outbreak in the country, which has so far seen 129 confirmed cases and 37 deaths, according to the Ministry of Health o...

Full Article
Single Dose Of Antibody Drug Provided Strong Protection Against Malaria, Study Shows

The Washington Post (10/31, Johnson) reports, “A single dose of an antibody drug provided strong protection against malaria infections during the six-month rainy season in Mali...researchers announced Monday.” The experimental drug, “CIS43LS, proved 88 pe...

Full Article
Four New RSV Vaccines May Be Close To FDA Review

CNN (10/31, Goodman) reports, “After decades of disappointment, four new RSV vaccines may be nearing review by the US Food and Drug Administration, and more than a dozen others are in testing.” There is “also hope around a promising long-acting injection...

Full Article
Multiple Drugmakers Developing Vaccines Against Pneumonia

The Wall Street Journal (10/31, Hopkins, Subscription Publication) reports drugmakers are working to upend Pfizer’s dominance in the global market for pneumonia vaccines, as companies including Merck, GSK, and Vaxcyte are developing shots to protect again...

Full Article
Death Toll From Malawi Cholera Outbreak Rises To 180, Health Minister Says

Reuters (10/31, Phiri) reports, “The death toll from a cholera outbreak in Malawi accelerated to 180 from 110 in October, the minister of health said on Monday.” The article adds, “The case fatality rate has risen to 3% from 2.8% recorded at the start of...

Full Article
Lebanon Receives First Cholera Vaccines Amid Worsening Outbreak

Reuters (10/31, Gebeily) reports, “Lebanon took delivery on Monday of its first vaccines to combat a worsening cholera outbreak – together with sharply worded criticism of the crisis-hit country’s crumbling public health infrastructure from donor nation F...

Full Article
Genital Viral Shedding Frequent After First-Episode Genital HSV-1 Infection, Study Finds

HealthDay (10/31) reports, “Genital viral shedding is frequent after first-episode genital herpes simplex virus type 1 (HSV-1) infection, particularly among those with primary infection, according to” an 82-patient study. The findings were published in JA...

Full Article
Record Number Of Cholera Outbreaks Worldwide Straining Vaccine Supply

The New York Times (10/31, A1, Nolen) reports, “A record number of cholera outbreaks around the globe, driven by droughts, floods and armed conflicts, has sickened hundreds of thousands of people and so severely strained the supply of cholera vaccines tha...

Full Article
Flu-Related Hospitalizations In US Reach Highest Levels In Over A Decade, CDC Says

ABC News (10/29, Benadjaoud, Egan) reported, “Flu season is making an early comeback as flu-related hospitalizations are the highest in over a decade for this point in the season, according to” CDC data issued Friday. The data revealed that “there have be...

Full Article
FDA Says Two Studies On Effectiveness Of New Omicron Boosters Too Small To Come To Conclusions

CNBC (10/28, Kimball) reported the FDA “said two studies...showing that the new Omicron boosters weren’t that much better than the old shots were too small to come to any real conclusions.” Researchers, “in two independent studies, found the new boosters...

Full Article
Influenza Reached Epidemic Levels In Chile Months Earlier Than Typical Season, May Portend Severe Season For Northern Hemisphere, Researchers Say

Healio (10/28, Feller) reported, “Influenza reached epidemic levels in Chile months earlier than a typical influenza season, just like in several other Southern Hemisphere countries, researchers reported.” And while “influenza activity in the Southern Hem...

Full Article
New Omicron Subvariants Responsible For Majority Of Infections In US, CDC Data Show

CNN (10/28, Goodman) reported, “The Omicron BA.5 subvariant is no longer the dominant cause of Covid-19 infections in the United States, according to estimates released Friday by the” CDC. And “instead, a host of new sublineages – offshoots of BA.2, BA.4...

Full Article
People With Either Treated Or Untreated HCV Have Increased Risk For Developing Active TB, Data Show

Healio (10/28, Stulpin) reported, “People with hepatitis C, either treated or untreated, had an increased risk for developing active tuberculosis, according to data” from “a large population-based cohort study involving more than 1.8 million adults from t...

Full Article
Fauci Says US Working On Developing RSV Vaccine, Urges Caution This Season

Reuters (10/28, Heavey) reported, “U.S. officials are working on a respiratory syncytial virus (RSV) vaccine, but until one is available people should exercise caution, especially seniors and parents of young children...said” NIAID Director Anthony Fauci,...

Full Article
Experts Raise Concern About Monkeypox Response In Rural US

Kaiser Health News (10/28, Rodriguez) reported, “Experts say the response to the monkeypox virus in rural America may be affected by the patchy resources and bitter politics that are a legacy of the pandemic, challenges that some worry could allow sporadi...

Full Article
Some Patients With COVID-19 Who Do Not Receive Treatment With Nirmatrelvir-Ritonavir Still Experience Rebound In Symptoms, Study Shows

The New York Times (10/27, Sheikh) reports a study “found that when patients” with COVID-19 “received a placebo instead of treatment” with nirmatrelvir-ritonavir (Paxlovid), “a portion of them still experienced a rebound of their symptoms after they had i...

Full Article
NIH To Study Nirmatrelvir-Ritonavir In Patients With Long COVID

Reuters (10/27, Steenhuysen) reports “the U.S. National Institutes of Health’s $1 billion RECOVER Initiative has picked Pfizer Inc’s antiviral drug” nirmatrelvir-ritonavir (Paxlovid) “as the first treatment it will study in patients with long COVID, organ...

Full Article

Request a Call from Customer Relations

Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id

First Name *
Last Name *
Email *
Customer ID

Questions Over Association Between COVID-19 Vaccine Reactions, Immunity Rise As People Receive New Boosters

Children’s Hospitals Struggling To Meet Demand Amid RSV Spike

CDC Issues Health Advisory Over Waterborne Bacteria In Dental Plumbing Systems After Outbreaks Of Nontuberculous Mycobacteria

Three Experimental Ebola Vaccine Candidates Sent To Uganda To Help Combat Outbreak

Single Dose Of Antibody Drug Provided Strong Protection Against Malaria, Study Shows

Four New RSV Vaccines May Be Close To FDA Review

Multiple Drugmakers Developing Vaccines Against Pneumonia

Death Toll From Malawi Cholera Outbreak Rises To 180, Health Minister Says

Lebanon Receives First Cholera Vaccines Amid Worsening Outbreak

Genital Viral Shedding Frequent After First-Episode Genital HSV-1 Infection, Study Finds

Record Number Of Cholera Outbreaks Worldwide Straining Vaccine Supply

Flu-Related Hospitalizations In US Reach Highest Levels In Over A Decade, CDC Says

FDA Says Two Studies On Effectiveness Of New Omicron Boosters Too Small To Come To Conclusions

Influenza Reached Epidemic Levels In Chile Months Earlier Than Typical Season, May Portend Severe Season For Northern Hemisphere, Researchers Say

New Omicron Subvariants Responsible For Majority Of Infections In US, CDC Data Show

People With Either Treated Or Untreated HCV Have Increased Risk For Developing Active TB, Data Show

Fauci Says US Working On Developing RSV Vaccine, Urges Caution This Season

Experts Raise Concern About Monkeypox Response In Rural US

Some Patients With COVID-19 Who Do Not Receive Treatment With Nirmatrelvir-Ritonavir Still Experience Rebound In Symptoms, Study Shows

NIH To Study Nirmatrelvir-Ritonavir In Patients With Long COVID